Skip to main content

Table 4 Results of molecular docking from PyRx software

From: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

No.

Molecule ID

FGFR3 protein

Binding affinity(kcal/mol)

Upper bind RMSD

Lower Bind RMSD

1

Ponatininb

− 10.0

0.0

0.0

2

Pemigatinib

− 8.1

0.0

0.0

3

Infigratinib

− 8.6

0.0

0.0

4

Nintedanib

− 9.1

0.0

0.0

5

ZINC09045651

− 8.3

0.0

0.0

6

ZINC08433190

− 9.2

0.0

0.0

7

ZINC00702764

− 8.2

0.0

0.0

8

ZINC00710252

− 8.3

0.0

0.0

9

ZINC00668789

− 9.1

0.0

0.0